Gabapentin and Cancidas drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Gabapentin (gabapentin) and Cancidas (caspofungin acetate). Common drug interactions include abdominal pain upper among females and arthralgia among males.
The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Cancidas. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.
What is Cancidas?
Cancidas has active ingredients of caspofungin acetate. eHealthMe is studying from 4,879 Cancidas users. Check the latest studies of Cancidas.
22 people who take Gabapentin and Cancidas together, and have interactions are studied.

What are the common drug interactions of Gabapentin and Cancidas, by gender? *:
female:
- Abdominal pain upper
- Disease progression
- Escherichia infection (bacterial infection by escherichia coli)
- Pyrexia (fever)
- Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
- Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
- Acute respiratory distress syndrome
- Agitation (state of anxiety or nervous excitement)
- Alanine aminotransferase increased
- Ammonia increased
male:
- Arthralgia (joint pain)
- Back pain
- Hearing impaired
- Acute respiratory failure
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Drug resistance (reduction in effectiveness of a drug)
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
- International normalised ratio increased
- Osteoporosis (bones weak and more likely to break)
- Pyrexia (fever)
What are the common drug interactions of Gabapentin and Cancidas, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Arthralgia (joint pain)
- Back pain
- Congestive cardiomyopathy (weakening of heart muscle)
- Diastolic dysfunction
- Dyspnoea exertional (breathlessness or shortness of breath)
- Osteonecrosis (death of bone)
- Systolic dysfunction (impaired ventricular contraction)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
20-29:
- Acute respiratory distress syndrome
- Alanine aminotransferase increased
- Ammonia increased
- Blood alkaline phosphatase increased
- Blood bilirubin increased
- Blood lactic acid increased
- Depression
- Drug ineffective
- Encephalitis (inflammation of the brain)
- Enterococcal infection
30-39:
- Renal failure acute on chronic (rapid or long lasting kidney failure)
- Drug resistance (reduction in effectiveness of a drug)
40-49:
- Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
- Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
- Agitation (state of anxiety or nervous excitement)
- Aspergillosis (an infection caused by a fungus called aspergillus)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Cytomegalovirus infection
- Engraftment syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation)
- Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
- Escherichia infection (bacterial infection by escherichia coli)
- Hepatotoxicity (chemical-driven liver damage)
50-59:
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
- Pyrexia (fever)
- Rash
60+:
- Abdominal pain upper
- Confusional state
- Hearing impaired
- Acute respiratory failure
- International normalised ratio increased
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 27.27%
- Pain: 5 people, 22.73%
- Neuropathy Peripheral (surface nerve damage): 3 people, 13.64%
- Nausea (feeling of having an urge to vomit): 3 people, 13.64%
- Indigestion: 3 people, 13.64%
- High Blood Pressure: 3 people, 13.64%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 13.64%
- Diarrhea: 3 people, 13.64%
- Cholangitis (infection of the bile duct): 3 people, 13.64%
- Bone Marrow Conditioning Regimen: 3 people, 13.64%
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and Cancidas?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gabapentin (322,983 reports)
- Cancidas (4,879 reports)
Browse all drug interactions of Gabapentin and Cancidas:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gabapentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cancidas:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gabapentin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cancidas and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- Biswal S, "Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins", Journal of pharmacology & pharmacotherapeutics, 2012 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- Biswal S, "Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins", Journal of pharmacology & pharmacotherapeutics, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin and caspofungin acetate (the active ingredients of Gabapentin and Cancidas, respectively), and Gabapentin and Cancidas (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Faslodex cause Neuralgia? - 5 seconds ago
- Drug interactions of Afinitor Disperz and Vigabatrin - 6 seconds ago
- Drug interactions of Imodium A-D and Apresoline - 31 seconds ago
- Drug interactions of Lyrica and Kadcyla - 40 seconds ago
- Could Letrozole cause Interstitial Nephritis? - 41 seconds ago
- Could Tylenol cause Aphonia? - 41 seconds ago
- Could Letrozole cause Nephritis - Interstitial? - 41 seconds ago
- Drug interactions of Montelukast Sodium and Pazeo - 53 seconds ago
- Drug interactions of Ninlaro and Loratadine - 57 seconds ago
- Could Cortisone Acetate cause Disseminated Intravascular Coagulation? - a minute ago